| http://www.w3.org/ns/prov#value | - Sanofi-Aventis (Paris) says it has signed an agreement to acquire TargeGen (San Diego, CA), a privately held biopharmaceutical company developing small molecule kinase inhibitors for the treatment of certain forms of leukemia, lymphoma and other hematological malignancies and blood disorders.
|
